Aurash Shahripour

Statistics

Publications

Citations

870

H-Index

Active since

1995

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Pfizer (United States)

Time Warner (United States)

IRBM Science Park

United States Military Academy

Aurash Shahripour is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in pharmacology, medicinal chemistry, and drug discovery.

Publications per year

1995–2021

Publications

A Series of Novel, Highly Potent, and Orally Bioavailable Next-Generation Tricyclic Peptide PCSK9 Inhibitors

Thomas J. Tucker, Mark W. Embrey, Candice Alleyne et al. · Journal of Medicinal Chemistry · 2021 · 152 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

Series of Novel and Highly Potent Cyclic Peptide PCSK9 Inhibitors Derived from an mRNA Display Screen and Optimized via Structure-Based Design

Candice Alleyne, Rupesh P. Amin, Bhavana Bhatt et al. · Journal of Medicinal Chemistry · 2020 · 128 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +14

Discovery of a Novel Series of Orally Active Non-Peptide Endothelin-A (ETA) Receptor-Selective Antagonists

Annette M. Doherty, William C. Patt, Jeremy J. Edmunds et al. · Journal of Medicinal Chemistry · 1995 · 109 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +11

Discovery of Selective Small Molecule ROMK Inhibitors as Potential New Mechanism Diuretics

Haifeng Tang, Shawn P. Walsh, Yan Yan et al. · ACS Medicinal Chemistry Letters · 2012 · 51 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +14

4-Anilino-5-carboxamido-2-pyridone Derivatives as Noncompetitive Inhibitors of Mitogen-Activated Protein Kinase Kinase

Julie A. Spicer, Gordon W. Rewcastle, Michael D. Kaufman et al. · Journal of Medicinal Chemistry · 2007 · 50 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +13

1–5 of 19